Kinetic analysis of fluorescein and dihydrofluorescein effluxes in tumour cells expressing the multidrug resistance protein,MRP1 |
| |
Authors: | Saengkhae Chantarawan Loetchutinat Chatchanok Garnier-Suillerot Arlette |
| |
Affiliation: | Laboratoire de Physicochimie Biomoléculaire et Cellulaire (LPBC-CSSB) UMR CNRS 7033, Université Paris Nord, 74 rue Marcel Cachin, 93017 Bobigny, France. |
| |
Abstract: | Multidrug resistance (MDR) in tumour cells is often caused by the overexpression of two transporters the P-glycoprotein (P-gp) and the multidrug resistance-associated protein (MRP1) which actively pump out multiple chemically unrelated substrates across the plasma membrane. A clear distinction in the mechanism of translocation of substrates by MRP1 or P-gp is indicated by the finding that, in most of cases, the MRP1-mediated transport of substrates is inhibited by depletion of intracellular glutathione (GSH), which has no effect on their P-gp-mediated transport. The aim of the present study was to quantitatively characterise the transport of anionic compounds dihydrofluorescein and fluorescein (FLU). We took advantage of the intrinsic fluorescence of FLU and performed a flow cytometric analysis of dye accumulation in the wild-type drug sensitive GLC4 that do not express MRP1 and its MDR subline which display high level of MRP1. The measurements were made in real time using intact cells. The kinetics parameters, k(a)=V(M)/K(m), which is a measure of the efficiency of the transporter-mediated efflux of a substrate, was very similar for the two FLU analogues. They were highly comparable with values for k(a) of other negatively charged substrates, such as GSH and calcein. The active efflux of both FLU derivatives was inhibited by GSH depletion. |
| |
Keywords: | MDR, multidrug resistance MRP1, multidrug resistance-associated protein P-gp, P-glycoprotein HRP, horse raddish peroxidase GSH, glutathione DHF-DA, dihydrofluorescein diacetate FLU, fluorescein DHF, dihydrofluorescein BSO, smallcaps" >l-buthionine-(S,R) sulphoximine PAK-104P, 2-[4-(diphenylmethyl)-1-piperazinyl]ethyl-5-(trans-4,6-dimethyl-1,3,2-dioxaphosphorinan-2-yl)-2,6-dimethyl-4-(3-nitrophenyl)-3-pyridinecarboxylate P oxide MK571, 3-([{3-(2-[7-chloro-2-quinolinyl]ethenyl)phenyl}-{(3-dimethylamino-3-oxopropyl)-thio}-methyl]thio)propanoic acid Ci, concentration of free intracellular FLU (or DHF) |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|